Drug Index
OMNIPEN (AMPICILLIN)
Generic: AMPICILLIN/AMPICILLIN TRIHYDRATE
Marketing status: Discontinued
- Route: ORAL
- Class: General Medications
- Safety profile: generic
- Latest regulatory update: 02 Apr 2026, 09:13 pm (UTC)
Structured Monograph
Approval overview OMNIPEN (AMPICILLIN) is listed in Drugs@FDA under application 060625 (ANDA). Marketing status: Discontinued Active ingredient AMPICILLIN/AMPICILLIN TRIHYDRATE Form and strength FOR SUSPENSION;ORAL - 500MG/5ML Sponsor WYETH AYERST Submission history See approval history documents.